rs61746932

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003611.3(OFD1):​c.1264A>G​(p.Lys422Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.001 in 1,204,450 control chromosomes in the GnomAD database, including 12 homozygotes. There are 317 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0054 ( 6 hom., 173 hem., cov: 22)
Exomes 𝑓: 0.00055 ( 6 hom. 144 hem. )

Consequence

OFD1
NM_003611.3 missense

Scores

3
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.15

Publications

3 publications found
Variant links:
Genes affected
OFD1 (HGNC:2567): (OFD1 centriole and centriolar satellite protein) This gene is located on the X chromosome and encodes a centrosomal protein. A knockout mouse model has been used to study the effect of mutations in this gene. The mouse gene is also located on the X chromosome, however, unlike the human gene it is not subject to X inactivation. Mutations in this gene are associated with oral-facial-digital syndrome type I and Simpson-Golabi-Behmel syndrome type 2. Many pseudogenes have been identified; a single pseudogene is found on chromosome 5 while as many as fifteen have been found on the Y chromosome. [provided by RefSeq, Aug 2016]
OFD1 Gene-Disease associations (from GenCC):
  • ciliopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • Joubert syndrome 10
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • orofaciodigital syndrome I
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 23
    Inheritance: XL Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • orofaciodigital syndrome type 6
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Simpson-Golabi-Behmel syndrome type 2
    Inheritance: XL Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0061338246).
BP6
Variant X-13756620-A-G is Benign according to our data. Variant chrX-13756620-A-G is described in ClinVar as [Benign]. Clinvar id is 159464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0054 (607/112378) while in subpopulation AFR AF = 0.0187 (578/30914). AF 95% confidence interval is 0.0174. There are 6 homozygotes in GnomAd4. There are 173 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 XL,AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OFD1NM_003611.3 linkc.1264A>G p.Lys422Glu missense_variant Exon 13 of 23 ENST00000340096.11 NP_003602.1 O75665-1E9KL37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OFD1ENST00000340096.11 linkc.1264A>G p.Lys422Glu missense_variant Exon 13 of 23 1 NM_003611.3 ENSP00000344314.6 O75665-1

Frequencies

GnomAD3 genomes
AF:
0.00540
AC:
607
AN:
112325
Hom.:
6
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0187
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00179
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00166
AC:
295
AN:
177743
AF XY:
0.00125
show subpopulations
Gnomad AFR exome
AF:
0.0206
Gnomad AMR exome
AF:
0.000991
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000229
GnomAD4 exome
AF:
0.000547
AC:
597
AN:
1092072
Hom.:
6
Cov.:
29
AF XY:
0.000402
AC XY:
144
AN XY:
358606
show subpopulations
African (AFR)
AF:
0.0191
AC:
498
AN:
26045
American (AMR)
AF:
0.00110
AC:
38
AN:
34440
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19231
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52807
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40480
Middle Eastern (MID)
AF:
0.000789
AC:
3
AN:
3800
European-Non Finnish (NFE)
AF:
0.0000107
AC:
9
AN:
839327
Other (OTH)
AF:
0.00107
AC:
49
AN:
45790
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
23
46
69
92
115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00540
AC:
607
AN:
112378
Hom.:
6
Cov.:
22
AF XY:
0.00501
AC XY:
173
AN XY:
34538
show subpopulations
African (AFR)
AF:
0.0187
AC:
578
AN:
30914
American (AMR)
AF:
0.00178
AC:
19
AN:
10656
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3601
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2726
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6123
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53291
Other (OTH)
AF:
0.00661
AC:
10
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00215
Hom.:
9
Bravo
AF:
0.00648
ESP6500AA
AF:
0.0214
AC:
82
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00188
AC:
228

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 29, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
May 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Joubert syndrome;C1510460:Orofaciodigital syndrome I Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Jan 07, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
9.3
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T;.;.;T
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.69
T;T;T;T
MetaRNN
Benign
0.0061
T;T;T;T
MetaSVM
Uncertain
0.11
D
MutationAssessor
Benign
1.7
L;.;.;.
PhyloP100
1.2
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.5
N;N;N;.
REVEL
Benign
0.25
Sift
Benign
0.077
T;T;D;.
Sift4G
Benign
0.25
T;T;T;T
Polyphen
0.25
B;B;B;.
Vest4
0.17
MVP
0.87
MPC
0.25
ClinPred
0.015
T
GERP RS
0.66
Varity_R
0.16
gMVP
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61746932; hg19: chrX-13774739; API